医学
肺炎
羟基氯喹
肺栓塞
阿奇霉素
急诊科
胸痛
2019年冠状病毒病(COVID-19)
病毒性肺炎
内科学
重症监护医学
放射科
疾病
传染病(医学专业)
抗生素
精神科
微生物学
生物
作者
Eleonora Secco,MariaCristina Pasqualetto,Fausto Rigo
出处
期刊:Journal of Cardiovascular Echography
[Medknow Publications]
日期:2020-01-01
卷期号:30 (2): 110-110
标识
DOI:10.4103/jcecho.jcecho_43_20
摘要
Coronavirus pneumonia (COVID-19) is a novel infectious disease with a high mortality rate due to severe acute respiratory syndrome. A 57-year-old woman was admitted to the emergency department (ED) with fever, cough, atypical chest pain, and dyspnea. She remained in the ED for about 48 h while waiting for the result of the COVID-19 oropharyngeal swab. Once she tested positive, she was hospitalized in the pneumological department with a diagnosis of pneumonia based on a chest X-ray and biochemical tests. Although azithromycin and hydroxychloroquine were promptly administered, she had a worsening of dyspnea even with a high-flow oxygen mask. D-dimer was increased, and a computed tomography scan with pulmonary and leg angiogram was positive for bilateral pulmonary embolism, deep-venous thrombosis, and multiple consolidated opacities in the lung parenchyma. This case highlights the fact that, in a pandemic situation, there is a potentially fatal risk of overlooking an alternative diagnosis in a COVID-19 patient who is generally considered as suffering only from pneumonia.
科研通智能强力驱动
Strongly Powered by AbleSci AI